Sunny Pharmtech, Inc. Issues Voluntary Nationwide Recall of Cyclophosphamide for Injection, USP to the User Level Due to the Presence of Particulate Matter

RegulatoryCyclophosphamide for Injection, USPNegative

AI Analysis

Summary

Sunny Pharmtech, Inc. issued a voluntary nationwide recall of three lots of Cyclophosphamide for Injection, USP due to the presence of steel particulate matter. No adverse events or injuries have been reported to date.

Outcome Details

Voluntary nationwide recall due to presence of particulate matter (steel) in three lots of Cyclophosphamide for Injection, USP (1g/vial and 2g/vial)

Importance:6/10

Sentiment:

-0.80

product recallquality controlparticulate mattersafety issueinjectable drug

Read the original article

Published by FDA MedWatch Safety Alerts on July 24, 2026 4:00 AM

Read Original